Literature DB >> 21862997

Inflammatory bowel disease of the elderly: frequently asked questions (FAQs).

Seymour Katz1, Darrell S Pardi.   

Abstract

The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65 beginning of 2011. It is anticipated that this will occur at a rate of 10,000 per day or 4 million per year for the next 19 years. The management of IBD in this population is complex because of problems with co-morbidities, polypharmacy, impaired mobility, and cognition, as well as difficult social and financial issues. This review focuses on the older IBD patient's unique concerns and provides guidance in their diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862997     DOI: 10.1038/ajg.2011.271

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  40 in total

Review 1.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

2.  The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.

Authors:  Chia-Jung Kuo; Kuang-Hui Yu; Lai-Chu See; Cheng-Tang Chiu; Ming-Yao Su; Chen-Ming Hsu; Chang-Fu Kuo; Meng-Jiun Chiou; Jia-Rou Liu; Hung-Wei Wang
Journal:  Dig Dis Sci       Date:  2015-04-03       Impact factor: 3.199

3.  Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.

Authors:  Yuying Luo; Emily N Tixier; Ari M Grinspan
Journal:  Dig Dis Sci       Date:  2020-02-20       Impact factor: 3.199

Review 4.  Medical and surgical complications of inflammatory bowel disease in the elderly: a systematic review.

Authors:  Dennis L Shung; Bincy Abraham; Joseph Sellin; Jason K Hou
Journal:  Dig Dis Sci       Date:  2014-12-12       Impact factor: 3.199

5.  Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

Authors:  Siddharth Singh; Larry W Stitt; Guangyong Zou; Reena Khanna; Parambir S Dulai; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2019-03-19       Impact factor: 8.171

Review 6.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

7.  Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Sasha Taleban
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 8.  Clinical outcomes and management of inflammatory bowel disease in the older patient.

Authors:  Christina Y Ha; Seymour Katz
Journal:  Curr Gastroenterol Rep       Date:  2013-02

9.  Diagnosis and treatment of inflammatory bowel disease in older patients.

Authors:  Christina Y Ha
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

10.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.